Latest Share Chat

UPDATE: e-Therapeutics Appoints Steve Medlicott Chief Financial Officer

Mon, 07th Apr 2014 12:25

LONDON (Alliance News) - e-Therapeutics PLC Monday said that it had appointed Steve Medlicott as Chief Financial Officer, following the resignation of Daniel Elger with immediate effect, also announced Monday.

Medlicott had advised the company on its GBP40 million fund-raising in 2013. Medlicott previously worked as finance director at Waste2Tricity Ltd, and co-founded Blueprint Advisors Ltd in 2012.

Shares in the biotechnology company were trading down 0.5% at 22.88 pence Monday afternoon.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Related Shares

More News

10 Apr 2024 12:32

e-Therapeutics proposes £29m fundraising, delisting from AIM

(Sharecast News) - RNAi medicines data and development specialist e-Therapeutics proposed a fundraise and its delisting from AIM on Wednesday.

10 Apr 2024 10:48

e-Therapeutics says company faces lack of interest as UK listing

(Alliance News) - e-Therapeutics PLC on Wednesday announced its intention to cancel its admission to AIM and instead explore the option of listing on ...

16 Jan 2024 10:34

IN BRIEF: e-Therapeutics shares rise on strong financial year

e-Therapeutics PLC - Oxford, England-based computer-based drug discovery company - Says 2023 was

27 Dec 2023 10:27

IN BRIEF: e-Therapeutics shares to cease trading on OTCQX

e-Therapeutics PLC - Oxford, England-based computer-based drug discovery company - Says that its shares will cease to trade on the OTCQX Best Market i...

2 Nov 2023 14:34

EARNINGS AND TRADING: Kanabo inks CBD deal, Taseko boosts production

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...